Navigation Links
Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
Date:6/8/2012

ies, including those discussed below and more fully described in the Securities and Exchange Commission (SEC) reports filed by Amgen, including Amgen's most recent annual report on Form 10-K and most recent periodic reports on Form 10-Q and Form 8-K. Please refer to Amgen's most recent Forms 10-K, 10-Q and 8-K for additional information on the uncertainties and risk factors related to our business. Unless otherwise noted, Amgen is providing this information as of June 8, 2012 and expressly disclaims any duty to update information contained in this news release.

No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, preclinical results do not guarantee safe and effective performance of product candidates in humans. The complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models. The length of time that it takes for us to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and we expect similar variability in the future. We develop product candidates internally and through licensing collaborations, partnerships and joint ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of entering into such relationship. Also, we or others could identify safety, side effects or manufacturing problems with our products after they are on the market. Our business may be impacted by
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
2. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
3. Amgen to Present at the Baird Growth Stock Conference
4. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
5. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
6. IntelliCell Announces Dr. Arnold I. Caplan Joins Scientific Advisory Board
7. GenVec Announces Conditional Approval of FMD Vaccine for Cattle
8. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
9. Brain Research Foundation Announces Grant To Study Concussive Events Among Grade School Children
10. ERT Announces Clearance from German Federal Cartel Office
11. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... Research and Markets( http://www.researchandmarkets.com/research/c8jldk/global_healthcare ) has announced the ... report to their offering. The Global ... and CRM BPO to grow at a CAGR of ... a segment of outsourcing, which consists of subcontracting the ... that has the expertise in the required domains. It ...
(Date:5/27/2015)... LOUIS , May 27, 2015   Mallinckrodt Pharmaceuticals ... will present on Wednesday, June 10, 2015, at the Goldman ... Resort in Rancho Palos Verdes, Calif. ... Mark Trudeau , President and Chief Executive Officer, and ... Investor Relations Officer, will represent the company in a session ...
(Date:5/27/2015)... ATLANTA , May 27, 2015  MT ... which operates lawsuitsettlementnews.com, reports today the most up-to-date ... including Stryker , DePuy, Wright, ... however, certain litigations are still dragging on and ... Stryker Corporation: Stryker Corporation has agreed to pay ...
Breaking Medicine Technology:Global Healthcare BPO Market 2015-2019 - Emergence of Cloud-based BPO in Healthcare with Accenture, Cognizant, Genpact, IBM, TCS, Wipro & Xerox Dominating 2Mallinckrodt To Present At Goldman Sachs 36th Annual Healthcare Conference 2Major Hip Settlements Reported by Lawsuitsettlementnews.com 2Major Hip Settlements Reported by Lawsuitsettlementnews.com 3
... HERZELIYA, Israel, September 30 Medical device ... round led by 7 Health,Ventures. Previous investors: Ofer ... as well. , ActiViews, ... used,in Computer Tomography (CT), fluoroscopy and Magnetic Resonance ...
... , JERUSALEM, Israel, September 30 ... evaluating carlecortemcel-l, the generic,name of what is widely known ... leukemia and lymphoma. The article, carlecortemcel-l, an ex vivo ... by,Dr. Ka Wah Chan and Dr. Demetrios Petropoulos, will ...
Cached Medicine Technology:Article Published in Expert Opinion on Biological Therapy Evaluates StemEx(R) (carlecortemcel-l) for Leukemia and Lymphoma 2Article Published in Expert Opinion on Biological Therapy Evaluates StemEx(R) (carlecortemcel-l) for Leukemia and Lymphoma 3
(Date:5/27/2015)... Representatives from Classified Advertising Plus, LLC, ... the American Immigration Lawyers Association (AILA). The conference takes ... booth is #404. , The annual event is billed ... a regular AILA conference attendee, describes it as “kind ... clients to their booth and make fresh friends among ...
(Date:5/27/2015)... 27, 2015 National Healthcare ... award winning web development and interactive marketing ... the launch of its newly redesigned, custom ... National Healthcare Providers, is a physician owned ... the areas of Radiology, Anesthesiology, Emergency and ...
(Date:5/27/2015)... Water, Inc. , an industry ... announced that its elite BG-12000 Body Glove Water ... pass the new NSF/ANSI Standard 401 – Pharmaceuticals: ... that the BG-12000 by Water, Inc. significantly reduces ... chemicals used in manufacturing that are currently found ...
(Date:5/27/2015)... Net Pistol proudly welcomes two new ... , The Mobility Van Store of Lakeland, Florida, is ... the mobility industry. They have a team of trained ... pre-owned wheelchair-accessible van, truck or car. Additionally, they provide ... chairs, three and four-wheel scooters, and manual wheelchairs. , ...
(Date:5/27/2015)... Chicago, IL (PRWEB) May 27, 2015 The ... Chicago office is open for business to better serve ... is in the Jefferson Park neighborhood on the Northwest side ... Chicago. Appointments can be arranged by calling the Chicago ... location for the Advanced Fertility Center of Chicago. The ...
Breaking Medicine News(10 mins):Health News:PERM Specialists from MCAads.com Will Attend the 2015 Conference on Immigration Law Set for June 17-20 in the DC Metro Area 2Health News:PERM Specialists from MCAads.com Will Attend the 2015 Conference on Immigration Law Set for June 17-20 in the DC Metro Area 3Health News:National Healthcare Providers Showcases Expanded Business Model with Launch of New Website 2Health News:National Healthcare Providers Showcases Expanded Business Model with Launch of New Website 3Health News:Water, Inc.’s BG-12000 Body Glove Water Filter System Receives NSF/ANSI Standard 401 Certification for Pharmaceutical Emerging Contaminant Reduction 2Health News:Water, Inc.’s BG-12000 Body Glove Water Filter System Receives NSF/ANSI Standard 401 Certification for Pharmaceutical Emerging Contaminant Reduction 3Health News:Net Pistol Continues Success Serving Mobility Dealers 2Health News:The Advanced Fertility Center of Chicago Opens a New Fertility Office Location in Chicago 2
... in combination with ribavirin for previously untreated children with ... , KENILWORTH, N.J., Dec. 12 ... announced that the U.S. Food and Drug Administration (FDA) ... REBETOL(R) (ribavirin, USP) combination therapy for use in previously ...
... Mich., Dec. 12 Terumo Corporation and Terumo,s,subsidiary, ... entered into an agreement to settle all outstanding ... a number of lawsuits pending,in which each claims ... litigations all,involve methods and devices used in endoscopic ...
... Dignity of a Person), an Instruction from the Vatican Congregation ... arising from biomedical research, provides guidance on how to respect ... said Cardinal Francis George of Chicago, president of the United ... "We welcome the Instruction as theologians, medical personnel, ...
... could also perpetuate more allergies among kids, , , FRIDAY, ... allergies are on the rise, with more and more ... are responding by providing nut-free areas. , But, at ... far, even creating hysteria over potential nut exposures. What,s ...
... up is hard,to do-but with the sixth annual ... all of the tools to help Americans ditch ... 2009. America,s largest and most,comprehensive multiplatform fitness ... provides participants unprecedented resources and,support -- online, on ...
... the launch of ATSU,s Women,s Wellness Program , ... ... noted scientist, author, and stroke survivor, joined A.T. Still University (ATSU) ... Program Nov. 18 at the Hilton Scottsdale Resort and Villas. Dr. ...
Cached Medicine News:Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 2Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 3Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 4Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 5Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 6Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 7Health News:Dignitas Personae, Vatican Instruction on Bioethics, Welcomed for Guidance on Issues of Procreation, Medical Research 2Health News:Dignitas Personae, Vatican Instruction on Bioethics, Welcomed for Guidance on Issues of Procreation, Medical Research 3Health News:Dignitas Personae, Vatican Instruction on Bioethics, Welcomed for Guidance on Issues of Procreation, Medical Research 4Health News:Nut Bans in Schools May Be Spurring Hysteria 2Health News:Nut Bans in Schools May Be Spurring Hysteria 3Health News:Discovery Health's NATIONAL BODY CHALLENGE Weighs in for a Sixth Season, Urging Americans to Break up With Bad Habits 2Health News:Discovery Health's NATIONAL BODY CHALLENGE Weighs in for a Sixth Season, Urging Americans to Break up With Bad Habits 3Health News:Discovery Health's NATIONAL BODY CHALLENGE Weighs in for a Sixth Season, Urging Americans to Break up With Bad Habits 4Health News:Jill Bolte Taylor Keynotes ATSU Women's Wellness Luncheon 2Health News:Jill Bolte Taylor Keynotes ATSU Women's Wellness Luncheon 3
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 7.5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 13.0 mm and length 15 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 9 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 8.0 mm and length 7 mm....
Medicine Products: